These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28461487)

  • 21. [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].
    Naĭkhin AN; Koren'kov DA; Chirkova TV; Petukhova GD; Donina SA; Rudenko LG
    Vopr Virusol; 2011; 56(5):15-21. PubMed ID: 22171472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus.
    Slütter B; Pewe LL; Kaech SM; Harty JT
    Immunity; 2013 Nov; 39(5):939-48. PubMed ID: 24238342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.
    Uddback IE; Pedersen LM; Pedersen SR; Steffensen MA; Holst PJ; Thomsen AR; Christensen JP
    Sci Rep; 2016 Feb; 6():20137. PubMed ID: 26831578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection.
    Oh S; Belz GT; Eichelberger MC
    Virology; 2001 Aug; 286(2):403-11. PubMed ID: 11485408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions.
    Coleclough C; Sealy R; Surman S; Marshall DR; Hurwitz JL
    Scand J Immunol; 2005 Jul; 62 Suppl 1():73-83. PubMed ID: 15953188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splenic priming of virus-specific CD8 T cells following influenza virus infection.
    Turner DL; Bickham KL; Farber DL; Lefrançois L
    J Virol; 2013 Apr; 87(8):4496-506. PubMed ID: 23388712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophils sustain effective CD8(+) T-cell responses in the respiratory tract following influenza infection.
    Tate MD; Brooks AG; Reading PC; Mintern JD
    Immunol Cell Biol; 2012 Feb; 90(2):197-205. PubMed ID: 21483446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.
    Porgador A; Staats HF; Itoh Y; Kelsall BL
    Infect Immun; 1998 Dec; 66(12):5876-81. PubMed ID: 9826368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes.
    Mbawuike IN; Zhang Y; Couch RB
    Respir Res; 2007 Jun; 8(1):44. PubMed ID: 17597533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization.
    Wu Y; Wei W; Zhou M; Wang Y; Wu J; Ma G; Su Z
    Biomaterials; 2012 Mar; 33(7):2351-60. PubMed ID: 22192540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site.
    Stevenson PG; Bangham CR; Hawke S
    Eur J Immunol; 1997 Dec; 27(12):3259-68. PubMed ID: 9464814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization.
    Gallichan WS; Rosenthal KL
    J Exp Med; 1996 Nov; 184(5):1879-90. PubMed ID: 8920875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.
    Marois I; Cloutier A; Garneau É; Lesur O; Richter MV
    FASEB J; 2015 Mar; 29(3):973-87. PubMed ID: 25414485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.
    Desai P; Abboud G; Stanfield J; Thomas PG; Song J; Ware CF; Croft M; Salek-Ardakani S
    J Immunol; 2017 Oct; 199(8):2968-2975. PubMed ID: 28864473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
    Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8
    Si Y; Wen Y; Kelly SH; Chong AS; Collier JH
    J Control Release; 2018 Jul; 282():120-130. PubMed ID: 29673645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease.
    Moraes TJ; Lin GH; Wen T; Watts TH
    Vaccine; 2011 Aug; 29(37):6301-12. PubMed ID: 21704101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.